Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Controlled Trial Comparing the Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass in Patients With Impaired Fasting Glucose or Early Type 2 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00775684
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:37.696090+00:00
Published At
2017-12-06T00:00:00+00:00
Record Updated At
2022-06-07
Results Posted At
2017-12-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pre-diabetes", "Type 2 Diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-06-07"
protocolSection.identificationModule.nctId
"NCT00775684"
protocolSection.identificationModule.officialTitle
"A Randomized, Controlled Trial Comparing the Effect of Exenatide, Sitagliptin or Glimepiride on Functional \u00df -Cell Mass in Patients With Impaired Fasting Glucose or Early Type 2 Diabetes"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-12-06"

Study condition terms

  • Pre-diabetes (protocolSection.conditionsModule.conditions)
  • Type 2 Diabetes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.